Study for Evaluation of the Safety, Pharmacokinetics, and Antiviral Activity of UB-421 Subcutaneous Formulation Administered in HIV-1 Infected Treatment Naive Patients
Clinical trial NCT04620304 · COMPLETED
Trial details
- NCT number
- NCT04620304
- Sponsor
- United BioPharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-01
- Primary completion
- 2022-05-25
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.